Hereditary Endocrine Tumor Registries

Area of Science:

• Endocrinology
• Genetics
• Clinical Research

Background:

• Hereditary endocrine tumors (HETs) are complex and often misunderstood as rare.
• Genetic factors are increasingly implicated, but true prevalence remains unclear.
• Clinical registries are vital for monitoring healthcare quality and improving patient outcomes.

Purpose of the Study:

• To identify and compare global registries collecting data on HETs.
• To analyze the characteristics and scope of existing HET registries.
• To highlight gaps and opportunities for registry development and data harmonization.

Main Methods:

• Systematic literature search of Ovid MEDLINE and EMBASE databases.
• Inclusion of registries focused on HETs with available clinical data.
• Exclusion of institutional audits, inactive registries, or those lacking clinical data.

Main Results:

• Fifteen registries specifically for HETs were identified.
• These registries were associated with 136 peer-reviewed publications.
• The majority of identified registries are European, with diverse data collection methods.

Conclusions:

• There is a limited number of HET-specific clinical registries globally.
• Existing registries exhibit significant variability in data collected.
• Further research on registry effectiveness is recommended, and opportunities exist for data harmonization and the development of new registries, such as in Australia.